Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

UCB

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of UCB's 2013 CNS (central nervous system) sales performance.

UCB

Amgen and UCB's romosozumab hits goals in male osteoporosis

Amgen and UCB's romosozumab hits goals in male osteoporosis A phase III study of Amgen and UCB's romosozumab in men with osteoporosis has met its objectives, adding to earlier positive data in post-menopausal women. ... Amgen and UCB previously reported data showing romosozumab was superior to Forteo, which also

Sanofi's sarilumab beats Humira in head-to-head trial

Sanofi's sarilumab beats Humira in head-to-head trial UCB had been developing its own candidate called olokizumab in phase II, but licensed it to Russia's R-Pharm in 2013.

Pharma's reputation rises, but pricing still a sore point

Pharma's reputation rises, but pricing still a sore point Gilead Sciences was sixth - a climb of three places - while Novartis, Roche, UCB and Pfizer rounded out the top 10.

FDA approves wireless contact lens sensor

FDA approves wireless contact lens sensor Wearable sensors are attracting increasing attention in healthcare, where the front-runners include UCB, which has begun trials of a wearable sensor to monitor the symptoms of Parkinson's disease, and

Pharma forms Parkinson's disease trials consortium

Pharma forms Parkinson's disease trials consortium Canada), Pfizer and UCB.

[ Previous 5 results ] 9 10 11 12 13 14 15 16 17 18 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics